Abstract
Objectives: Vaccination remains the most effective approach for preventing infectious diseases. Rapid cell-based virus propagation can enable high yields of vaccines, offering critical value during emergent situations like viral pandemics. Methods: This study investigates the biological mechanisms underlying redox-triggered cell survival to enhance viral particle production. Results: Cold atmospheric plasma (CAP), containing reactive oxygen and nitrogen species like $H_2O_2$, effectively enhances virus replication by triggering cell mitophagy. This process is dynamically modulated by the p-EGFR(Tyr1068)/p-Drp1(Ser616) axis. Removing $H_2O_2$ further enhances virus yield by releasing cells from excessive $G_0/G_1$ cell cycle arrest. Efficacy was demonstrated across IBRV, CDV, and CPV models. Conclusion: CAP serves as a promising tool for modulating cell survival and mitophagy to enhance viral vaccine yields.
Introduction
Vaccine manufacturing is a critical race against time during global health crises. While cell-based manufacturing using mammalian cells is flexible, it is often hampered by low viral titers and high production costs. This research explores a novel application for Cold Atmospheric Plasma (CAP). Traditionally used for disinfection or oncology, CAP is here repurposed as a biological "booster" to modulate host cell behavior in favor of viral replication.
Methods and Experimental Design
The researchers utilized a Helium-based CAP ejection device to generate Plasma Activated Medium (PAM). The primary model system involved Infectious Bovine Rhinotracheitis Virus (IBRV) and MDBK cells, with additional validation performed on Canine Distemper (CDV) and Parvovirus (CPV).
Key methodologies included:
- Viral Quantification: TCID50 assays and qRT-PCR were used to measure viral load and replication rates.
- Genetic Engineering: CRISPR/Cas9 was employed to create a point mutation in the host cell's EGFR gene (Tyr1068 to Phe1068) to verify the necessity of this phosphorylation site.
- Transcriptomics: RNA-Sequencing identified global changes and the inhibitory role of $H_2O_2$.
- Molecular Imaging: Immunofluorescence and Co-Immunoprecipitation confirmed the physical interactions between signaling proteins (EGFR and Drp1) and their mitochondrial localization.
Results
CAP-Induced Viral Titer Enhancement
Exposure to CAP for 4 minutes resulted in a significant increase in IBRV titers, rising from $10^{2.57}/mL$ to $10^{4.5}/mL$—nearly a 100-fold boost. This enhancement was accompanied by a decrease in cycle thresholds (CT) in qPCR assays, indicating higher viral RNA levels.
Mitophagy and the EGFR/Drp1 Signaling Axis
The study identified mitophagy—the selective autophagy of mitochondria—as a key driver of the viral boost. CAP-induced reactive oxygen species (ROS) trigger the phosphorylation of EGFR at Tyr1068. This activated EGFR interacts with Drp1 (Ser616), a protein that promotes mitochondrial fission, thereby initiating mitophagy. Western blot analysis confirmed the upregulation of the autophagy marker LC3B and the downregulation of p62, consistent with increased autophagic flux.
Optimization via $H_2O_2$ Scavenging
While CAP boosts yield, the researchers discovered a paradoxical effect: the $H_2O_2$ component of the plasma cocktail induces $G_0/G_1$ cell cycle arrest, which eventually limits total biomass. By introducing an $H_2O_2$ scavenger (such as sodium pyruvate), they were able to release cells from this arrest, further maximizing the viral output beyond the initial CAP-induced levels.
Conclusion
This study provides robust experimental evidence that CAP can be used as a precise modulator of cell survival mechanisms. By hijacking the EGFR-mediated mitophagy pathway, CAP significantly increases the efficiency of cell-based virus production. These findings suggest that CAP is a promising industrial tool for rapid, high-yield vaccine manufacturing, provided that challenges regarding large-scale engineering and host-virus generality are addressed in future research.
Summary updated